Your Shopping Cart Is Empty
| Report Code: A10567 | Mar 2021 | Pages: 268 | ||
| Tables: 120 | Charts: 66 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Copd And Asthma Diagnostic And Monitoring Devices Market
Request Now !The global COPD and asthma diagnostic and monitoring devices market size was accounted for $4,953.60 million in 2019, and is expected to reach $8,202.62 million by 2027, registering a CAGR of 6.3% from 2020 to 2027.
The market for COPD and asthma diagnostic and monitoring devices is experiencing exponential growth due to the COVID-19 pandemic. The COVID-19 is essentially a respiratory ailment has boosted the use of COPD and asthma diagnostic and monitoring devices to monitor the physiological functions of lungs during COVID-19 treatment. This is anticipated to increase the demand of product and drives the market growth in the near future.
The COPD and asthma diagnostic and monitoring devices are used for assessment, diagnosis, and care of patients suffering from lung diseases such as COPD & asthma. As the functioning of lungs deteriorate with growing age, the respiratory system undergoes various physiological, functional, and immunological changes. Rise in incidences of chronic pulmonary diseases and asthma drives the growth of the market. Furthermore, these devices can be used in hospitals and in-home care settings as they have developed from stationary to portable ones.
The COPD and asthma diagnostic and monitoring devices market is positively impacted as the spread of Coronavirus (COVID-19) persists throughout the global community. The key market players are supporting the health systems and healthcare professionals actively. For instance, Phillips is providing solutions including invasive and non-invasive ventilation ranging from mid- to high-acuity, patient monitoring, medical consumable, and others. Furthermore, the market for COPD and asthma diagnostic and monitoring devices is experiencing exponential growth due to the COVID-19 pandemic. The fact that COVID-19 is essentially a respiratory ailment has boosted the use of COPD and asthma diagnostic and monitoring devices to monitor the physiological functions of lungs during COVID-19 treatment. This is anticipated to increase the demand of product and drives the COPD and asthma diagnostic and monitoring devices market growth in the near future.
Moreover, air pollution, climate changes, and allergies are further driving the market growth. The development of technologically advanced devices, regulatory approvals, and product launches drives the market growth. However, high costs of the device and stringent regulatory procedures impede the market growth. Moreover, increase in initiatives taken by authorities and governments to improve healthcare systems and spread awareness regarding benefits of COPD and asthma diagnostic and monitoring devices are also expected to drive the growth of the global COPD and asthma diagnostic and monitoring devices market.
Rise in lifestyle habits such as smoking, consumption of alcohol, and an increase in the geriatric population is a significant factor boosting the market. Technological advances for new devices, regulatory approvals, and product launches are further promoting the market growth. The prevalence of air pollution, climate changes, and dust is also fueling the market growth. Moreover, rise in prevalence of respiratory diseases is increasing globally. In 2017, according to the WHO, respiratory diseases were considered to be the leading causes of death and disability in the world. Nearly 65 million people suffer from COPD, and 3 million are expected to die from it each year, making it the third leading cause of death across the world. Moreover, approximately 334 million people suffer from asthma, the most common chronic disease of childhood, affecting 14% of all children globally. On the contrary, surge in number of regulations promote use of COPD and asthma diagnostic and monitoring devices and increase in funds for research in developing countries are expected to offer lucrative opportunities for the market in the future.
The global COPD and asthma devices market is segmented on the basis of product, indication, end user, and region. Based on the product, the market is segmented into diagnostic devices, monitoring devices, and consumables and accessories. Furthermore, the diagnostic devices segment includes spirometers electrocardiogram, FeNo test analyzer, peak flow meter, arterial blood gas analyzer (ABG), polysomnography devices, and others. The monitoring devices segment includes pulse oximeters, capnograph, asthma monitors, portable table top pulse oximeter, wearable devices, Fourier transform infrared spectroscopy (FTIR), others. The consumables and accessories segment includes masks, spirometry accessories, polysomnography accessories, peak flow meter accessories, pulse oximeter sensors, capnography accessories, gas analyzer accessories, and others. Based on indication, the market is divided into asthma and COPD. Based on end user, it is segregated into hospitals & clinics, home care settings, and others. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
On the basis of product type, the diagnostic devices segment is expected to maintain its dominant position throughout the forecast period. This is attributed to increase in investment by the giant players and increase in research related funding made it convenient to use them, which further made them portable and automatic. All these factors are expected to propel growth of the COPD and asthma diagnostic and monitoring devices market during the forecast period. In addition, by indication, the asthma segment dominated the market in 2019, owing to rise in prevalence of asthma patients across the globe.
By end user, the hospitals & clinics segment is expected to grow at the highest CAGR during the forecast period. This is attributed to rise in number of patients diagnosed with respiratory diseases, increase in government initiatives, and technological upgradation in COPD & asthma devices.
Asia-Pacific presents lucrative opportunities for key players operating in the COPD and asthma diagnostic and monitoring devices market, owing to increase in population coupled with high growing geriatric population. Furthermore, growth in awareness among healthcare entities drives the market growth. In addition, rise in healthcare expenditure and developing approval guidelines are expected to propel the market growth in the region.
The report provides a comprehensive analysis of the leading companies operating in the global COPD and asthma diagnostic and monitoring devices market are Becton Dickinson And Company, Drägerwerk AG & CO. KGAA, Getinge AB, Invacare Corporation, Masimo Corporation, Medtronic Plc, Koninklijke Philips N.V, Nihon Kohden Corporation, Smiths Medical, and Vyaire Medical Inc.
Key Benefits For Stakeholders
COPD and Asthma Diagnostic and Monitoring Devices Market Report Highlights
| Aspects | Details |
|---|---|
| By Product |
|
| By Indication |
|
| By End User |
|
| By Region |
|
| Key Market Players | MASIMO CORPORATION, INVACARE CORPORATION, KONINKLIJKE PHILIPS N.V., GETINGE AB, MEDTRONIC PLC, NIHON KOHDEN CORPORATION, BECTON DICKINSON AND COMPANY, SMITHS MEDICAL, DRAGERWERK AG & CO. KGAA, VYAIRE MEDICAL |
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.List of key players profiled in the report
1.4.Research methodology
1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.1.1.Top winning strategies, 2019
3.2.Top player positioning
3.2.1.Top investment pockets
3.3.Key forces shaping global COPD and asthma diagnostic and monitoring device market industry/market
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Daily exposure to environmental pollution
3.4.1.2.Increase in population susceptible to indoor air pollutants
3.4.1.3.Portability of the drug delivery devices
3.4.1.4.Increase in population of active smokers
3.4.1.5.Growth in number of surgeries
3.4.2.Restraints
3.4.2.1.High costs of the device
3.4.2.2.Stringent regulatory procedures
3.4.3.Opportunities
3.4.3.1.High growth potential in emerging markets
3.4.3.2.Increase in geriatric population
3.4.4.Impact analysis
3.5.COVID-19 impact analysis for the COPD and asthma diagnostic and monitoring device market
3.6.Volume and average sales price analysis of India and China of COPD and asthma diagnostic and monitoring device market
CHAPTER 4:COPD AND ASTHMA DIAGNOSTIC AND MONITORING
DEVICES MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Diagnostic devices
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market share analysis, by country
4.2.3.1.Market size and forecast, by type
4.2.3.2.Spirometers
4.2.3.3.Market size and forecast
4.2.3.4.Electrocardiogram
4.2.3.5.Market size and forecast
4.2.3.6.FeNo test analyzer
4.2.3.7.Market size and forecast
4.2.3.8.Arterial blood gas analyzer (ABG)
4.2.3.9.Market size and forecast
4.2.3.10.Polysomnography devices
4.2.3.11.Market size and forecast
4.2.3.12.Peak flow meters
4.2.3.13.Market size and forecast
4.2.3.14.Others
4.2.3.15.Market size and forecast
4.3.Monitoring devices
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market share analysis, by country
4.3.3.1.Market size and forecast, by type
4.3.3.2.Pulse oximeters
4.3.3.3.Market size and forecast
4.3.3.4.Capnographs
4.3.3.5.Market size and forecast
4.3.3.6.Asthma monitors
4.3.3.7.Market size and forecast
4.3.3.8.Portable table top pulse oximeter
4.3.3.9.Market size and forecast
4.3.3.10.Wearable devices
4.3.3.11.Market size and forecast
4.3.3.12.Fourier transform infrared spectroscopy (FTIR)
4.3.3.13.Market size and forecast
4.3.3.14.Others
4.3.3.15.Market size and forecast
4.4.Consumables and accessories
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market share analysis, by country
4.4.3.1.Market size and forecast, by type
4.4.3.2.Masks
4.4.3.3.Market size and forecast
4.4.3.4.Spirometry accessories
4.4.3.5.Market size and forecast
4.4.3.6.Polysomnography accessories
4.4.3.7.Market size and forecast
4.4.3.8.Peak flow meter accessories
4.4.3.9.Market size and forecast
4.4.3.10.Pulse oximeter sensors
4.4.3.11.Market size and forecast
4.4.3.12.Capnography accessories
4.4.3.13.Market size and forecast
4.4.3.14.Gas analyzer accessories
4.4.3.15.Market size and forecast
4.4.3.16.Others
4.4.3.17.Market size and forecast
CHAPTER 5:COPD AND ASTHMA DIAGNOSTIC AND MONITORING
DEVICES MARKET, BY INDICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Asthma
5.2.1.Market size and forecast
5.2.2.Market share analysis, by country
5.3.COPD
5.3.1.Market size and forecast
5.3.2.Market share analysis, by country
CHAPTER 6:COPD AND ASTHMA DIAGNOSTIC AND MONITORING
DEVICES MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals and clinics
6.2.1.Market size and forecast
6.2.2.Market share analysis, by country
6.3.Home care settings
6.3.1.Market size and forecast
6.3.2.Market share analysis, by country
6.4.Others
6.4.1.Market size and forecast
6.4.2.Market share analysis, by country
CHAPTER 7:COPD AND ASTHMA DIAGNOSTIC AND MONITORING
DEVICES MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.North America market size and forecast, by country
7.2.3.North America market size and forecast, by product
7.2.4.North America market size and forecast, by indication
7.2.5.North America market size and forecast, by end user
7.2.5.1.U.S. market size and forecast
7.2.5.1.1.Market size and forecast, by product
7.2.5.1.2.Market size and forecast, by indication
7.2.5.1.3.Market size and forecast, by end user
7.2.5.3.Canada market size and forecast
7.2.5.3.1.Market size and forecast, by product
7.2.5.3.2.Market size and forecast, by indication
7.2.5.3.3.Market size and forecast, by end user
7.2.5.4.Mexico market size and forecast
7.2.5.4.1.Market size and forecast, by product
7.2.5.4.2.Market size and forecast, by indication
7.2.5.4.3.Market size and forecast, by end user
7.3.Europe
7.3.1.Key market trends and opportunities
7.3.2.Europe market size and forecast, by country
7.3.3.Europe market size and forecast, by product
7.3.4.Europe market size and forecast, by indication
7.3.5.Europe market size and forecast, by end user
7.3.5.1.Germany market size and forecast
7.3.5.1.1.Market size and forecast, by product
7.3.5.1.2.Market size and forecast, by indication
7.3.5.1.3.Market size and forecast, by end user
7.3.5.2.France market size and forecast
7.3.5.2.1.Market size and forecast, by product
7.3.5.2.2.Market size and forecast, by indication
7.3.5.2.3.Market size and forecast, by end user
7.3.5.3.UK market size and forecast
7.3.5.3.1.Market size and forecast, by product
7.3.5.3.2.Market size and forecast, by indication
7.3.5.3.3.Market size and forecast, by end user
7.3.5.4.Italy market size and forecast
7.3.5.4.1.Market size and forecast, by product
7.3.5.4.2.Market size and forecast, by indication
7.3.5.4.3.Market size and forecast, by end user
7.3.5.5.Spain market size and forecast
7.3.5.5.1.Market size and forecast, by product
7.3.5.5.2.Market size and forecast, by indication
7.3.5.5.3.Market size and forecast, by end user
7.3.5.6.Rest of Europe market size and forecast
7.3.5.6.1.Market size and forecast, by product
7.3.5.6.2.Market size and forecast, by indication
7.3.5.6.3.Market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key market trends and opportunities
7.4.2.Asia-Pacific market size and forecast, by country
7.4.3.Asia-Pacific market size and forecast, by product
7.4.4.Asia-Pacific market size and forecast, by indication
7.4.5.Asia-Pacific market size and forecast, by end user
7.4.5.1.China market size and forecast
7.4.5.1.1.Market size and forecast, by product
7.4.5.1.2.Market size and forecast, by indication
7.4.5.1.3.Market size and forecast, by end user
7.4.5.2.Japan market size and forecast
7.4.5.2.1.Market size and forecast, by product
7.4.5.2.2.Market size and forecast, by indication
7.4.5.2.3.Market size and forecast, by end user
7.4.5.3.India market size and forecast
7.4.5.3.1.Market size and forecast, by product
7.4.5.3.2.Market size and forecast, by indication
7.4.5.3.3.Market size and forecast, by end user
7.4.5.4.Australia market size and forecast
7.4.5.4.1.Market size and forecast, by product
7.4.5.4.2.Market size and forecast, by indication
7.4.5.4.3.Market size and forecast, by end user
7.4.5.5.South Korea market size and forecast
7.4.5.5.1.Market size and forecast, by product
7.4.5.5.2.Market size and forecast, by indication
7.4.5.5.3.Market size and forecast, by end user
7.4.5.6.Rest of Asia-Pacific market size and forecast
7.4.5.6.1.Market size and forecast, by product
7.4.5.6.2.Market size and forecast, by indication
7.4.5.6.3.Market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.LAMEA market size and forecast, by country
7.5.3.LAMEA market size and forecast, by product
7.5.4.LAMEA market size and forecast, by indication
7.5.5.LAMEA market size and forecast, by end user
7.5.5.1.Brazil market size and forecast
7.5.5.1.1.Market size and forecast, by product
7.5.5.1.2.Market size and forecast, by indication
7.5.5.1.3.Market size and forecast, by end user
7.5.5.2.Saudi Arabia market size and forecast
7.5.5.2.1.Market size and forecast, by product
7.5.5.2.2.Market size and forecast, by indication
7.5.5.2.3.Market size and forecast, by end user
7.5.5.3.South Africa market size and forecast
7.5.5.3.1.Market size and forecast, by product
7.5.5.3.2.Market size and forecast, by indication
7.5.5.3.3.Market size and forecast, by end user
7.5.5.4.Rest of LAMEA market size and forecast
7.5.5.4.1.Market size and forecast, by product
7.5.5.4.2.Market size and forecast, by indication
7.5.5.4.3.Market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.BECTON DICKINSON AND COMPANY
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.DRAGERWERK AG & CO. KGAA
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.GETINGE AB
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.INVACARE CORPORATION
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.5.MASIMO CORPORATION
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.MEDTRONIC PLC
8.6.1.Company overview
8.6.2.Operating business segments
8.6.3.Product portfolio
8.6.4.Business performance
8.7.NIHON KOHDEN CORPORATION
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.KONINKLIJKE PHILIPS N.V.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.SMITHS MEDICAL
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.VYAIRE MEDICAL
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Key strategic moves and developments
LIST OF TABLES
TABLE 01.COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET
TABLE 02.COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET
TABLE 03.COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019-2027 ($MILLION)
TABLE 04.DIAGNOSTIC DEVICES COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY REGION 2019-2027, ($MILLION)
TABLE 05.DIAGNOSTIC DEVICES COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY TYPE
2019-2027, ($MILLION)
TABLE 06.MONITORING DEVICES COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY REGION 2019-2027, ($MILLION)
TABLE 07.MONITORING DEVICES COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY TYPE 2019-2027, ($MILLION)
TABLE 08.CONSUMABLES AND ACCESSORIES COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES
MARKET, BY REGION 2019-2027, ($MILLION)
TABLE 09.CONSUMABLES AND ACCESSORIES COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES
MARKET, BY TYPE 2019-2027, ($MILLION)
TABLE 10.COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019-2027 ($MILLION)
TABLE 11.ASTHMA COPD ANDS ASTHMA DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 12.COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY REGION,
2019-2027 ($MILLION)
TABLE 13.COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019-2027 ($MILLION)
TABLE 14.HOSPITALS AND CLINICS COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY REGION, 2019-2027 ($MILLION)
TABLE 15.HOME CARE SETTINGS COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY REGION, 2019-2027 ($MILLION)
TABLE 16.OTHERS COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY REGION,
2019-2027 ($MILLION)
TABLE 17.GLOBAL COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY REGION
2019-2027 ($MILLION)
TABLE 18.NORTH AMERICA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY COUNTRY, 2019–2027 ($MILLION)
TABLE 19.NORTH AMERICA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY PRODUCT, 2019–2027 ($MILLION)
TABLE 20.NORTH AMERICA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY INDICATION, 2019–2027 ($MILLION)
TABLE 21.NORTH AMERICA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY END USER, 2019–2027 ($MILLION)
TABLE 22.U.S. COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 23.U.S. COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 24.U.S. COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 25.CANADA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 26.CANADA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 27.CANADA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 28.MEXICO COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 29.MEXICO COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 30.MEXICO COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 31.EUROPE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY COUNTRY,
2019–2027 ($MILLION)
TABLE 32.EUROPE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 33.EUROPE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 34.EUROPE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 35.GERMANY COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 36.GERMANY COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 37.GERMANY COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 38.FRANCE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 39.FRANCE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 40.FRANCE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 41.UK COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 42.UK COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 43.UK COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 44.ITALY COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 45.ITALY COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 46.ITALY COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 47.SPAIN COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 48.SPAIN COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 49.SPAIN COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 50.REST OF EUROPE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY PRODUCT, 2019–2027 ($MILLION)
TABLE 51.REST OF EUROPE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY INDICATION, 2019–2027 ($MILLION)
TABLE 52.REST OF EUROPE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY END USER, 2019–2027 ($MILLION)
TABLE 53.ASIA-PACIFIC COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY COUNTRY,
2019–2027 ($MILLION)
TABLE 54.ASIA-PACIFIC COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 55.ASIA-PACIFIC COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 56.ASIA-PACIFIC COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 57.CHINA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 58.CHINA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 59.CHINA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 60.JAPAN COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 61.JAPAN COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 62.JAPAN COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 63.INDIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 64.INDIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 65.INDIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 66.AUSTRALIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 67.AUSTRALIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 68.AUSTRALIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 69.SOUTH KOREA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 70.SOUTH KOREA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION, 2019–2027 ($MILLION)
TABLE 71.SOUTH KOREA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 72.REST OF ASIA-PACIFIC COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY PRODUCT, 2019–2027 ($MILLION)
TABLE 73.REST OF ASIA-PACIFIC COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY INDICATION, 2019–2027 ($MILLION)
TABLE 74.REST OF ASIA-PACIFIC COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY END USER, 2019–2027 ($MILLION)
TABLE 75.LAMEA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY COUNTRY,
2019–2027 ($MILLION)
TABLE 76.LAMEA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 77.LAMEA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 78.LAMEA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 79.BRAZIL COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 80.BRAZIL COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 81.BRAZIL COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 82.SAUDI ARABIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 83.SAUDI ARABIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION, 2019–2027 ($MILLION)
TABLE 84.SAUDI ARABIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 85.SOUTH AFRICA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 86.SOUTH AFRICA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY INDICATION, 2019–2027 ($MILLION)
TABLE 87.SOUTH AFRICA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 88.REST OF LAMEA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY PRODUCT, 2019–2027 ($MILLION)
TABLE 89.REST OF LAMEA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY INDICATION, 2019–2027 ($MILLION)
TABLE 90.REST OF LAMEA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY END USER, 2019–2027 ($MILLION)
TABLE 91.BD: COMPANY SNAPSHOT
TABLE 92.BD: OERATING SEGMENT
TABLE 93.BD: PRODUCT PORTFOLIO
TABLE 94.DRAGER: COMPANY SNAPSHOT
TABLE 95.DRAGER: OERATING SEGMENT
TABLE 96.DRAGER: PRODUCT PORTFOLIO
TABLE 97.GETINGE: COMPANY SNAPSHOT
TABLE 98.GETINGE: OERATING SEGMENT
TABLE 99.GETINGE: PRODUCT PORTFOLIO
TABLE 100.INVACARE CORPORATION: COMPANY SNAPSHOT
TABLE 101.INVACARE CORPORATION: OERATING SEGMENT
TABLE 102.INVACARE CORPORATION: PRODUCT PORTFOLIO
TABLE 103.MASIMO: COMPANY SNAPSHOT
TABLE 104.MASIMO: OERATING SEGMENT
TABLE 105.MASIMO: PRODUCT PORTFOLIO
TABLE 106.MEDTRONIC: COMPANY SNAPSHOT
TABLE 107.MEDTRONIC: OERATING SEGMENT
TABLE 108.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 109.NIHON KOHDEN: COMPANY SNAPSHOT
TABLE 110.NIHON KOHDEN: OERATING SEGMENT
TABLE 111.NIHON KOHDEN: PRODUCT PORTFOLIO
TABLE 112.PHILIPS.: COMPANY SNAPSHOT
TABLE 113.PHILIPS.: OERATING SEGMENT
TABLE 114.PHILIPS.: PRODUCT PORTFOLIO
TABLE 115.SMITHS MEDICAL: COMPANY SNAPSHOT
TABLE 116.SMITHS MEDICAL: OERATING SEGMENT
TABLE 117.SMITHS MEDICAL: PRODUCT PORTFOLIO
TABLE 118.VYAIRE MEDICAL: COMPANY SNAPSHOT
TABLE 119.VYAIRE MEDICAL: OERATING SEGMENT
TABLE 120.VYAIRE MEDICAL: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICE MARKET SEGMENTATION
FIGURE 02.TOP WINNING STRATEGIES, BY DEVELOPMENTS, 2017–2021*
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017–2021*
FIGURE 04.TOP WINNING STRATEGIES: COMPANY, 2017–2021
FIGURE 05.TOP PLAYER POSITIONING, 2019
FIGURE 06.TOP INVESTMENT POCKETS
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.MODERATE BARGAINING POWER OF BUYERS
FIGURE 09.MODERATE THREAT OF SUBSTITUTES
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.HIGH THREAT OF NEW ENTRANTS
FIGURE 12.IMPACT ANALYSIS, COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICE MARKET
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC DEVICES COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 14.GLOBAL SPIROMETERS MARKET, 2019–2027 ($MILLION)
FIGURE 15.GLOBAL ELECTROCARDIOGRAM MARKET, 2019–2027 ($MILLION)
FIGURE 16.GLOBAL FENO TEST ANALYZER MARKET, 2019–2027 ($MILLION)
FIGURE 17.GLOBAL ARTERIAL BLOOD GAS ANALYZER (ABG) MARKET, 2019–2027 ($MILLION)
FIGURE 18.GLOBAL POLYSOMNOGRAPHY DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 19.GLOBAL PEAK FLOW METERS MARKET, 2019–2027 ($MILLION)
FIGURE 20.GLOBAL OTHERS MARKET, 2019–2027 ($MILLION)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF MONITORING DEVICES COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 22.GLOBAL PULSE OXIMETERS MARKET, 2019–2027 ($MILLION)
FIGURE 23.GLOBAL CAPNOGRAPHS MARKET, 2019–2027 ($MILLION)
FIGURE 24.GLOBAL ASTHMA MONITORS MARKET, 2019–2027 ($MILLION)
FIGURE 25.GLOBAL PORTABLE TABLE TOP PULSE OXIMETER MARKET, 2019–2027 ($MILLION)
FIGURE 26.GLOBAL WEARABLE DEVICESMARKET, 2019–2027 ($MILLION)
FIGURE 27.GLOBAL FOURIER TRANSFORM INFRARED SPECTROSCOPY (FTIR) MARKET, 2019–2027 ($MILLION)
FIGURE 28.GLOBAL OTHERS MARKET, 2019–2027 ($MILLION)
FIGURE 29.COMPARATIVE SHARE ANALYSIS OF CONSUMABLES AND ACCESSORIES COPD AND ASTHMA
DIAGNOSTIC AND MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 30.GLOBAL MASKS MARKET, 2019–2027 ($MILLION)
FIGURE 31.GLOBAL SPIROMETRY ACCESSORIES MARKET, 2019–2027 ($MILLION)
FIGURE 32.GLOBAL POLYSOMNOGRAPHY ACCESSORIES MARKET, 2019–2027 ($MILLION)
FIGURE 33.GLOBAL PEAK FLOW METER ACCESSORIES MARKET, 2019–2027 ($MILLION)
FIGURE 34.GLOBAL PULSE OXIMETER SENSORSMARKET, 2019–2027 ($MILLION)
FIGURE 35.GLOBAL CAPNOGRAPHY ACCESSORIES MARKET, 2019–2027 ($MILLION)
FIGURE 36.GLOBAL GAS ANALYZER ACCESSORIESMARKET, 2019–2027 ($MILLION)
FIGURE 37.GLOBAL OTHERS MARKET, 2019–2027 ($MILLION)
FIGURE 38.COMPARATIVE SHARE ANALYSIS OF ASTHMA COPD AND ASTHMA DIAGNOSTIC AND MONITORING
DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 39.COMPARATIVE SHARE ANALYSIS OF COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES
MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 40.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS COPD AND ASTHMA DIAGNOSTIC
AND MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 41.COMPARATIVE SHARE ANALYSIS OF HOME CARE SETTINGS COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 42.COMPARATIVE SHARE ANALYSIS OF OTHERS COPD AND ASTHMA DIAGNOSTIC AND MONITORING
DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 43.BD: NET SALES, 2018–2020 ($MILLION)
FIGURE 44.BD: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 45.BD: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 46.DRAGER: NET SALES, 2017–2019 ($MILLION)
FIGURE 47.DRAGER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 48.DRAGER: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 49.GETINGE: NET SALES, 2017–2019 ($MILLION)
FIGURE 50.GETINGE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 51.GETINGE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 52.INVACARE CORPORATION: NET SALES, 2017–2019 ($MILLION)
FIGURE 53.INVACARE CORPORATION: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 54.INVACARE CORPORATION: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 55.MASIMO: NET SALES, 2017–2019 ($MILLION)
FIGURE 56.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 57.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 58.MEDTRONIC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 59.NIHON KOHDEN: NET SALES, 2017–2019 ($MILLION)
FIGURE 60.NIHON KOHDEN: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 61.PHILIPS.: NET SALES, 2018–2020 ($MILLION)
FIGURE 62.PHILIPS: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 63.PHILIPS: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 64.SMITHS MEDICAL: NET SALES, 2019–2020 ($MILLION)
FIGURE 65.SMITHS MEDICAL: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 66.SMITHS MEDICAL: REVENUE SHARE, BY REGION, 2020 (%)
According to CXO perspective, COPD and asthma diagnostic and monitoring devices is expected to witness significant growth, owing to increase in cases of diseases such as asthma & COPD across the globe.
There are remarkable technological advancements in monitoring devices to improve screening of severe chronic obstructive pulmonary diseases (COPDs). Asia-Pacific and LAMEA are expected to offer lucrative growth opportunities to the key players in the industry.
Rise in incidences of lung diseases, growth in aging population, technological advancements, and increase in emphasis on monitoring of COPD patients are some of the factors that majorly drive the market growth. Furthermore, rise in population in active smokers and the prevalence of air pollution, climate changes, and dust is also fueling the market growth. However, high cost of few COPD & asthma monitoring devices and stringent regulatory procedures hamper the market growth.
In addition, COPD and asthma monitoring and diagnostic device manufacturers and distributors focus to expand their presence in emerging economies to increase their market outreach.
A. The total market value of COPD and Asthma Diagnostic and Monitoring Device market is $4953.6 million in 2019.
A. The forcast period for COPD and Asthma Diagnostic and Monitoring Device market is 2020 to 2027
A. The market value of COPD and Asthma Diagnostic and Monitoring Device market in 2027 is $8202.62 million.
A. The base year is 2019 in COPD and Asthma Diagnostic and Monitoring Device market.
A. Becton Dickinson And Company, Drägerwerk AG & CO. KGAA, Getinge AB, Invacare Corporation held a high market postion owing to the strong geographical foothold in different regions.
A. Diagnostic devices segment is most influencing segnment in the COPD and asthma diagnostic and monitoring device market. This is attributed to increase in investment by the giant players and increase in research related funding made it convenient to use them, which further made them portable and automatic. All these factors are expected to propel growth of the market during the forecast period.
A. The major factor for the growth of COPD and Asthma Diagnostic and Monitoring Device market are rise in prevalence of respiratory diseases, huge demand for enhanced portable devices, growth in geriatric population, and high prevalence of tobacco smoking are expected to drive the market growth.
A. Due to increase in population, coupled with high growing geriatric population and growth in awareness among healthcare entities and patients pertaining to potential of these devices in chronic disease management, and rise in healthcare expenditure and developing guidelines are expected to propel the market growth in the region.
A. COPD and asthma diagnostic and monitoring devices are used for assessment, diagnosis, and care of patients suffering from lung diseases who is having difficulty in breathing and cannot achieve adequate oxygen levels to maintain life.
A. "COPD and asthma diagnostic and monitoring devices helps in diagnosis of respiratory distress, provide real-time feedback on treatment effects, and detect shock.
Start reading instantly.
This Report and over 67,068+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report